The European Food Safety Authority (EFSA) has published its final guidance to applicants on the submission of health claims for authorisation.
The guidance will help companies who want to submit health claims for authorisation. It addresses what they need to include in their application, in particular concerning the scientific data and evidence required to support claims.
EFSA has given the opportunity to Member States and stakeholders to comment on the draft guidance document on disease risk reduction claims and claims for children. Altogether some 300 comments were received which all were thoroughly considered by the NDA Panel (Panel on dietetic products, nutrition and allergies).
In order to make the document clearer, simpler and more user-friendly examples have also been added to assist the applicants.
The issue of consumer understanding was perceived as one of the key topics. In the event of a favourable opinion, the NDA Panel will evaluate the wording of the health claim proposed by the applicant. In doing so, the Panel will seek to ensure that it reflects the scientific evidence and is understandable in terms of its relevance for human health.
EFSA expects now to receive the first applications as regards disease reduction claims and claims referring to children’s development and health.
Following a completeness check and the formal acceptance of the validated dossiers the Panel will assess the health claim and provide a scientific opinion within 5 months.
Source: European Food Safety Authority (EFSA)